DOCSLIB.ORG

Cells Phenotype of Human Tolerogenic Dendritic Glycolytic Capacity Represent a Metabolic High Mitochondrial Respiration

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cells Phenotype of Human Tolerogenic Dendritic Glycolytic Capacity Represent a Metabolic High Mitochondrial Respiration High Mitochondrial Respiration and Glycolytic Capacity Represent a Metabolic Phenotype of Human Tolerogenic Dendritic Cells This information is current as of October 1, 2021. Frano Malinarich, Kaibo Duan, Raudhah Abdull Hamid, Au Bijin, Wu Xue Lin, Michael Poidinger, Anna-Marie Fairhurst and John E. Connolly J Immunol 2015; 194:5174-5186; Prepublished online 27 April 2015; Downloaded from doi: 10.4049/jimmunol.1303316 http://www.jimmunol.org/content/194/11/5174 Supplementary http://www.jimmunol.org/content/suppl/2015/04/25/jimmunol.130331 http://www.jimmunol.org/ Material 6.DCSupplemental References This article cites 35 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/194/11/5174.full#ref-list-1 Why The JI? Submit online. by guest on October 1, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology High Mitochondrial Respiration and Glycolytic Capacity Represent a Metabolic Phenotype of Human Tolerogenic Dendritic Cells Frano Malinarich,*,† Kaibo Duan,† Raudhah Abdull Hamid,*,† Au Bijin,*,† Wu Xue Lin,*,† Michael Poidinger,† Anna-Marie Fairhurst,† and John E. Connolly*,†,‡ Human dendritic cells (DCs) regulate the balance between immunity and tolerance through selective activation by environmental and pathogen-derived triggers. To characterize the rapid changes that occur during this process, we analyzed the underlying met- abolic activity across a spectrum of functional DC activation states, from immunogenic to tolerogenic. We found that in contrast to the pronounced proinflammatory program of mature DCs, tolerogenic DCs displayed a markedly augmented catabolic pathway, related to oxidative phosphorylation, fatty acid metabolism, and glycolysis. Functionally, tolerogenic DCs demonstrated the highest mitochondrial oxidative activity, production of reactive oxygen species, superoxide, and increased spare respiratory capacity. Fur- Downloaded from thermore, assembled, electron transport chain complexes were significantly more abundant in tolerogenic DCs. At the level of gly- colysis, tolerogenic and mature DCs showed similar glycolytic rates, but glycolytic capacity and reserve were more pronounced in tolerogenic DCs. The enhanced glycolytic reserve and respiratory capacity observed in these DCs were reflected in a higher met- abolic plasticity to maintain intracellular ATP content. Interestingly, tolerogenic and mature DCs manifested substantially different expression of proteins involved in the fatty acid oxidation (FAO) pathway, and FAO activity was significantly higher in tolerogenic DCs. Inhibition of FAO prevented the function of tolerogenic DCs and partially restored T cell stimulatory capacity, demonstrating http://www.jimmunol.org/ their dependence on this pathway. Overall, tolerogenic DCs show metabolic signatures of increased oxidative phosphorylation pro- graming, a shift in redox state, and high plasticity for metabolic adaptation. These observations point to a mechanism for rapid genome-wide reprograming by modulation of underlying cellular metabolism during DC differentiation. The Journal of Immu- nology, 2015, 194: 5174–5186. endritic cell (DC) maturation status plays a key role in processes require energetic metabolic adaptations important for regulating the balance between immunity and tolerance DC survival, migration, and ultimately the development of pathogen- D (1, 2). DC maturation is a tightly coordinated response specific immunity. Understanding the metabolic changes underpin- by guest on October 1, 2021 involving multiple signaling pathways, molecular trafficking, cy- ning DC immune function could help develop new strategies for tokine production, and cytoskeletal remodeling (3–5). These controlling immunogenicity. Studies in mice have demonstrated that T cell activation and differentiation from naive into effector and memory T cells are processes highly dependent on energetic *Institute of Molecular and Cell Biology, Agency for Science, Technology and metabolic adaptations. This knowledge is currently being con- Research, Singapore 138673; †Singapore Immunology Network, Singapore 138648; and ‡Institute of Biomedical Studies, Baylor University, Waco, TX 76798 sidered for potential novel immune therapies (6–8). However, knowledge surrounding the immune-metabolic states of DCs is Received for publication December 11, 2013. Accepted for publication March 18, 2015. rather limited. This work was supported by Agency for Science, Technology and Research Core Maturation of murine bone marrow–derived DCs (BMDCs) is Funding (to J.E.C.). highly dependent on metabolic changes. In the immature state, The microarray data presented in this article have been submitted to the National oxidative phosphorylation (OXPHOS) and fatty acid oxidation Center for Biotechnology Information’s Gene Expression Omnibus (http://www.ncbi. (FAO) are the main energy sources. DC maturation coincides with nlm.nih.gov/geo/query/acc.cgi?token=arwhicsyrnchxmb&acc=GSE52894) under ac- cession number GSE52894. an increase in mitochondrial OXPHOS followed by a pronounced Address correspondence and reprint requests to Dr. John E. Connolly, Institute of switch to aerobic glycolysis (9–11). Importantly, pharmacological Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Room 7-17B, Singapore inhibition of glycolysis prevents BMDC maturation, suggesting 138673. E-mail address: [email protected] the importance of this metabolic switch for DC immunogenicity The online version of this article contains supplemental material. (10, 11). Abbreviations used in this article: ACADM, acyl-CoA dehydrogenase, C-4 to C-12 Consistent with the studies in mice, downregulation of OXPHOS straight chain; BMDC, bone marrow–derived DC; CM-H2DCFDA, 5-(and-6)-chlor- omethyl-29,79-dichlorodihydrofluorescein diacetate, acetyl ester; COXII, cyclooxy- gene expression has been reported during human monocyte-derived genase II; DC, dendritic cell; DEG, differentially expressed gene; 2-DG, 2-deoxy-D- DC (moDC) maturation (12). In contrast to mature moDCs, pro- glucose; ECAR, extracellular acidification rate; FAO, fatty acid oxidation; FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; HADHA, hydroxyacyl-CoA teomic analysis of tolerogenic moDCs, which are resistant to dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase, a subunit; HADHB, maturation (13), has shown a predominance of OXPHOS pathway hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase, b subunit; iNOS, inducible NO synthase; IPA, ingenuity pathway analysis; LDHB, lactate proteins (14). Therefore, a comparative analysis across the spec- dehydrogenase B; moDC, monocyte-derived DC; OCR, oxygen consumption rate; trum of moDCs is required to explain the metabolic changes be- OXPHOS, oxidative phosphorylation; ROS, reactive oxygen species; SO, superoxide; tween immunogenic and tolerogenic moDC states. SRC, spare respiratory capacity. In this study, we compared the changes in energetic metabolism Copyright Ó 2015 by The American Association of Immunologists, Inc. 0022-1767/15/$25.00 among human moDCs. Protein expression and functional analyses www.jimmunol.org/cgi/doi/10.4049/jimmunol.1303316 The Journal of Immunology 5175 demonstrated that tolerogenic moDCs have a prominent and stable panel kits (Millipore), respectively, using a FLEXMAP 3D system OXPHOS program with high reactive oxygen species (ROS) and (Luminex). superoxide (SO) production, as well as a robust mitochondrial spare Mitochondrial DNA content determination respiratory capacity (SRC). Although tolerogenic and immature moDCs displayed similar levels of FAO activity, glycolytic ca- Total DNA from moDCs was isolated by phenol-chloroform extraction as pacity, and reserve, these catabolic pathways were maintained at previously described (15). Real-time PCR was performed in the Stratagene Mx3005P quantitative PCR system using the SYBR Green/ROX FAST a low level in mature moDCs. Finally, tolerogenic moDCs, in contrast Mastermix kit (Qiagen) with GAPDH (forward, 59-CCTAGGGCTGCT- to mature moDCs, demonstrate a high bioenergetic plasticity for CACATATTC-39, reverse: 59-CGCCCAATACGACCAAATCTA-39)and metabolic adaptation in terms of ATP production. cyclooxygenase II (COXII; forward: 59-GTTGTAGCCCACTTCCAC- TATG, reverse: TAGGGTGTAGCCTGAGAATAGG-39)primers.The mitochondrial/nuclear DNA content was calculated by using the formula: Materials and Methods 22CT mitochondrial COXII/22CT nuclear GAPDH. Data were analyzed by MxPro moDC generation quantitative PCR software (Agilent Technologies). Monocytes were purified from PBMCs of healthy donors (Institutional Real-time metabolic characterization Review Board approval NUS-IRB 10-250) by density centrifugation (Ficoll–Paque, GE Healthcare), followed by magnetic
Load more

Recommended publications
  • Genome-Wide Analysis of 5-Hmc in the Peripheral Blood of Systemic Lupus Erythematosus Patients Using an Hmedip-Chip
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 35: 1467-1479, 2015 Genome-wide analysis of 5-hmC in the peripheral blood of systemic lupus erythematosus patients using an hMeDIP-chip WEIGUO SUI1*, QIUPEI TAN1*, MING YANG1, QIANG YAN1, HUA LIN1, MINGLIN OU1, WEN XUE1, JIEJING CHEN1, TONGXIANG ZOU1, HUANYUN JING1, LI GUO1, CUIHUI CAO1, YUFENG SUN1, ZHENZHEN CUI1 and YONG DAI2 1Guangxi Key Laboratory of Metabolic Diseases Research, Central Laboratory of Guilin 181st Hospital, Guilin, Guangxi 541002; 2Clinical Medical Research Center, the Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong 518020, P.R. China Received July 9, 2014; Accepted February 27, 2015 DOI: 10.3892/ijmm.2015.2149 Abstract. Systemic lupus erythematosus (SLE) is a chronic, Introduction potentially fatal systemic autoimmune disease characterized by the production of autoantibodies against a wide range Systemic lupus erythematosus (SLE) is a typical systemic auto- of self-antigens. To investigate the role of the 5-hmC DNA immune disease, involving diffuse connective tissues (1) and modification with regard to the onset of SLE, we compared is characterized by immune inflammation. SLE has a complex the levels 5-hmC between SLE patients and normal controls. pathogenesis (2), involving genetic, immunologic and envi- Whole blood was obtained from patients, and genomic DNA ronmental factors. Thus, it may result in damage to multiple was extracted. Using the hMeDIP-chip analysis and valida- tissues and organs, especially the kidneys (3). SLE arises from tion by quantitative RT-PCR (RT-qPCR), we identified the a combination of heritable and environmental influences. differentially hydroxymethylated regions that are associated Epigenetics, the study of changes in gene expression with SLE.
    [Show full text]
  • Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins
    International Journal of Molecular Sciences Article Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins M. Quadir Siddiqui 1,† , Maulik D. Badmalia 1,† and Trushar R. Patel 1,2,3,* 1 Alberta RNA Research and Training Institute, Department of Chemistry and Biochemistry, University of Lethbridge, 4401 University Drive, Lethbridge, AB T1K 3M4, Canada; [email protected] (M.Q.S.); [email protected] (M.D.B.) 2 Department of Microbiology, Immunology and Infectious Disease, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive, Calgary, AB T2N 4N1, Canada 3 Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB T6G 2E1, Canada * Correspondence: [email protected] † These authors contributed equally to the work. Abstract: Members of the human Zyxin family are LIM domain-containing proteins that perform critical cellular functions and are indispensable for cellular integrity. Despite their importance, not much is known about their structure, functions, interactions and dynamics. To provide insights into these, we used a set of in-silico tools and databases and analyzed their amino acid sequence, phylogeny, post-translational modifications, structure-dynamics, molecular interactions, and func- tions. Our analysis revealed that zyxin members are ohnologs. Presence of a conserved nuclear export signal composed of LxxLxL/LxxxLxL consensus sequence, as well as a possible nuclear localization signal, suggesting that Zyxin family members may have nuclear and cytoplasmic roles. The molecular modeling and structural analysis indicated that Zyxin family LIM domains share Citation: Siddiqui, M.Q.; Badmalia, similarities with transcriptional regulators and have positively charged electrostatic patches, which M.D.; Patel, T.R.
    [Show full text]
  • Differential Expression Profile Prioritization of Positional Candidate Glaucoma Genes the GLC1C Locus
    LABORATORY SCIENCES Differential Expression Profile Prioritization of Positional Candidate Glaucoma Genes The GLC1C Locus Frank W. Rozsa, PhD; Kathleen M. Scott, BS; Hemant Pawar, PhD; John R. Samples, MD; Mary K. Wirtz, PhD; Julia E. Richards, PhD Objectives: To develop and apply a model for priori- est because of moderate expression and changes in tization of candidate glaucoma genes. expression. Transcription factor ZBTB38 emerges as an interesting candidate gene because of the overall expres- Methods: This Affymetrix GeneChip (Affymetrix, Santa sion level, differential expression, and function. Clara, Calif) study of gene expression in primary cul- ture human trabecular meshwork cells uses a positional Conclusions: Only1geneintheGLC1C interval fits our differential expression profile model for prioritization of model for differential expression under multiple glau- candidate genes within the GLC1C genetic inclusion in- coma risk conditions. The use of multiple prioritization terval. models resulted in filtering 7 candidate genes of higher interest out of the 41 known genes in the region. Results: Sixteen genes were expressed under all condi- tions within the GLC1C interval. TMEM22 was the only Clinical Relevance: This study identified a small sub- gene within the interval with differential expression in set of genes that are most likely to harbor mutations that the same direction under both conditions tested. Two cause glaucoma linked to GLC1C. genes, ATP1B3 and COPB2, are of interest in the con- text of a protein-misfolding model for candidate selec- tion. SLC25A36, PCCB, and FNDC6 are of lesser inter- Arch Ophthalmol. 2007;125:117-127 IGH PREVALENCE AND PO- identification of additional GLC1C fami- tential for severe out- lies7,18-20 who provide optimal samples for come combine to make screening candidate genes for muta- adult-onset primary tions.7,18,20 The existence of 2 distinct open-angle glaucoma GLC1C haplotypes suggests that muta- (POAG) a significant public health prob- tions will not be limited to rare descen- H1 lem.
    [Show full text]
  • Uncovering Cancer Gene Regulation by Accurate Regulatory Network Inference from Uninformative Data
    www.nature.com/npjsba ARTICLE OPEN Uncovering cancer gene regulation by accurate regulatory network inference from uninformative data Deniz Seçilmiş 1, Thomas Hillerton1, Daniel Morgan 1, Andreas Tjärnberg 2, Sven Nelander3, Torbjörn E. M. Nordling 4 and ✉ Erik L. L. Sonnhammer 1 The interactions among the components of a living cell that constitute the gene regulatory network (GRN) can be inferred from perturbation-based gene expression data. Such networks are useful for providing mechanistic insights of a biological system. In order to explore the feasibility and quality of GRN inference at a large scale, we used the L1000 data where ~1000 genes have been perturbed and their expression levels have been quantified in 9 cancer cell lines. We found that these datasets have a very low signal-to-noise ratio (SNR) level causing them to be too uninformative to infer accurate GRNs. We developed a gene reduction pipeline in which we eliminate uninformative genes from the system using a selection criterion based on SNR, until reaching an informative subset. The results show that our pipeline can identify an informative subset in an overall uninformative dataset, allowing inference of accurate subset GRNs. The accurate GRNs were functionally characterized and potential novel cancer-related regulatory interactions were identified. npj Systems Biology and Applications (2020) 6:37 ; https://doi.org/10.1038/s41540-020-00154-6 1234567890():,; INTRODUCTION where the main aim is to improve the SNR of the dataset by Living organisms are orchestrated by the biochemical reactions permanently removing the least informative genes and their that occur as a result of the interactions between biomolecules.
    [Show full text]
  • Profiling and Validation of the Circular RNA Repertoire in Adult Murine Hearts
    Accepted Manuscript Profiling and Validation of the Circular RNA Repertoire in Adult Murine Hearts Tobias Jakobi, Lisa F. Czaja-Hasse, Richard Reinhardt, Christoph Dieterich PII: S1672-0229(16)30033-X DOI: http://dx.doi.org/10.1016/j.gpb.2016.02.003 Reference: GPB 200 To appear in: Genomics, Proteomics & Bioinformatics Received Date: 20 November 2015 Revised Date: 19 January 2016 Accepted Date: 15 February 2016 Please cite this article as: T. Jakobi, L.F. Czaja-Hasse, R. Reinhardt, C. Dieterich, Profiling and Validation of the Circular RNA Repertoire in Adult Murine Hearts, Genomics, Proteomics & Bioinformatics (2016), doi: http:// dx.doi.org/10.1016/j.gpb.2016.02.003 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Profiling and Validation of the Circular RNA Repertoire in Adult Murine Hearts Tobias Jakobi1,2,*,a, Lisa F. Czaja-Hasse3,b , Richard Reinhardt3,c, Christoph Dieterich1,2,d 1Section of Bioinformatics and Systems Cardiology, Department of Internal Medicine III, University Hospital Heidelberg, Heidelberg D-69120, Germany 2 German Centre for Cardiovascular Research (DZHK), partner site Heidelberg / Mannheim, Heidelberg D-69120, Germany 3Max Planck-Genome-Centre Cologne, Cologne D-50829, Germany * Corresponding author. E-mail: [email protected] (Jakobi T).
    [Show full text]
  • Analysis of Gene Expression in Intracranial Aneurysms Jia Wang1,2, Lanbing Yu1, Dong Zhang1, Shuo Wang1 and Jizong Zhao1,2,3,4*
    Wang et al. Chinese Neurosurgical Journal (2017) 3:34 DOI 10.1186/s41016-017-0098-z ˖ӧӝߥ͗ᇷፂܰመߥѫ͗ CHINESE NEUROSURGICAL SOCIETY CHINESE MEDICAL ASSOCIATION RESEARCH Open Access Analysis of gene expression in intracranial aneurysms Jia Wang1,2, Lanbing Yu1, Dong Zhang1, Shuo Wang1 and Jizong Zhao1,2,3,4* Abstract Background: Different gene expression profiles are observed in intracranial aneurysm tissue. Understanding these genes and what regulates their expression will help us to understand intracranial aneurysm pathogenesis. We investigated whether differences in gene expression in intracranial aneurysms. Methods: Sixteen intracranial aneurysm tissues were compared with 16 matched samples from the superficial temporal artery as controls. We detected the gene expression profiles in these samples with the Human U133 Plus 2.0 GeneChip. Results: A total of 2142 differentially expressed gene transcripts were detected based on the gene expression profile. Verification analysis showed that the VCAM1, MAGI2, PPP2R2B, PPP2R3A genes were associated with the occurrence and development of intracranial aneurysm. These genes mainly encode cell adhesion molecules (CAMs) and ERK/JNK signaling pathways. Conclusion: Changes of genes expression involved in immune and inflammatory reactions, cell adhesion molecules may be associated with the development of aneurysms. Keywords: Intracranial aneurysm, Gene expression profile, Microarray analysis Background understanding gene expression and their regulating fac- Intracranial aneurysmal subarachnoid hemorrhage is asso- tors in intracranial aneurysms remains crucial for under- ciated with high mortality and morbidity [1]. The risk fac- standing its pathogenesis. tors for intracranial aneurysms include smoking, drinking, This study selected the tissue of intracranial aneurysm aging, female gender, hypertension, drug abuse, and use of and superficial temporal artery of the same patients as medicinethat can lead to arteriosclerosis and hypertension control group to discuss the mechanism of intracranial [2].
    [Show full text]
  • Primepcr™Assay Validation Report
    PrimePCR™Assay Validation Report Gene Information Gene Name protein phosphatase 2, regulatory subunit B'', alpha Gene Symbol PPP2R3A Organism Human Gene Summary This gene encodes one of the regulatory subunits of the protein phosphatase 2. Protein phosphatase 2 (formerly named type 2A) is one of the four major Ser/Thr phosphatases and is implicated in the negative control of cell growth and division. Protein phosphatase 2 holoenzymes are heterotrimeric proteins composed of a structural subunit A a catalytic subunit C and a regulatory subunit B. The regulatory subunit is encoded by a diverse set of genes that have been grouped into the B/PR55 B'/PR61 and B''/PR72 families. These different regulatory subunits confer distinct enzymatic specificities and intracellular localizations to the holozenzyme. The product of this gene belongs to the B'' family. The B'' family has been further divided into subfamilies. The product of this gene belongs to the alpha subfamily of regulatory subunit B''. Alternative splicing results in multiple transcript variants encoding different isoforms. Gene Aliases PPP2R3, PR130, PR72 RefSeq Accession No. NC_000003.11, NT_005612.16 UniGene ID Hs.518155 Ensembl Gene ID ENSG00000073711 Entrez Gene ID 5523 Assay Information Unique Assay ID qHsaCID0018097 Assay Type SYBR® Green Detected Coding Transcript(s) ENST00000264977, ENST00000490467, ENST00000334546, ENST00000492624 Amplicon Context Sequence GGAGAGAAGACAGGATTTGTGACAGCACAGTCATTCATTGCCATGTGGAGAAAG TTGCTGAATAACCATCATGATGATGCCTCTAAATTCATCTGTCTTCTAGCAAAGCC CAACTGCAGCTC Amplicon Length (bp) 92 Chromosome Location 3:135759752-135768169 Assay Design Intron-spanning Purification Desalted Validation Results Efficiency (%) 98 Page 1/5 PrimePCR™Assay Validation Report R2 0.9982 cDNA Cq 22.01 cDNA Tm (Celsius) 79.5 gDNA Cq 42.67 Specificity (%) 100 Information to assist with data interpretation is provided at the end of this report.
    [Show full text]
  • Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors
    University of Cincinnati Date: 12/20/2010 I, Arturo R Maldonado , hereby submit this original work as part of the requirements for the degree of Doctor of Philosophy in Developmental Biology. It is entitled: Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors Student's name: Arturo R Maldonado This work and its defense approved by: Committee chair: Jeffrey Whitsett Committee member: Timothy Crombleholme, MD Committee member: Dan Wiginton, PhD Committee member: Rhonda Cardin, PhD Committee member: Tim Cripe 1297 Last Printed:1/11/2011 Document Of Defense Form Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors A dissertation submitted to the Graduate School of the University of Cincinnati College of Medicine in partial fulfillment of the requirements for the degree of DOCTORATE OF PHILOSOPHY (PH.D.) in the Division of Molecular & Developmental Biology 2010 By Arturo Rafael Maldonado B.A., University of Miami, Coral Gables, Florida June 1993 M.D., New Jersey Medical School, Newark, New Jersey June 1999 Committee Chair: Jeffrey A. Whitsett, M.D. Advisor: Timothy M. Crombleholme, M.D. Timothy P. Cripe, M.D. Ph.D. Dan Wiginton, Ph.D. Rhonda D. Cardin, Ph.D. ABSTRACT Since 1999, cancer has surpassed heart disease as the number one cause of death in the US for people under the age of 85. Malignant Peripheral Nerve Sheath Tumor (MPNST), a common malignancy in patients with Neurofibromatosis, and colorectal cancer are midkine- producing tumors with high mortality rates. In vitro and preclinical xenograft models of MPNST were utilized in this dissertation to study the role of midkine (MDK), a tumor-specific gene over- expressed in these tumors and to test the efficacy of a MDK-transcriptionally targeted oncolytic HSV-1 (oHSV).
    [Show full text]
  • Non‑Small‑Cell Lung Cancer Pathological Subtype‑Related Gene
    356 MOLECULAR AND CLINICAL ONCOLOGY 8: 356-361, 2018 Non‑small‑cell lung cancer pathological subtype‑related gene selection and bioinformatics analysis based on gene expression profiles JIANGPENG CHEN1, XIAOQI DONG2, XUN LEI1, YINYIN XIA1, QING ZENG1, PING QUE1, XIAOYAN WEN1, SHAN HU1 and BIN PENG1 1School of Public Health and Management, Chongqing Medical University, Chongqing 400016; 2Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China Received March 21, 2016; Accepted November 21, 2017 DOI: 10.3892/mco.2017.1516 Abstract. Lung cancer is one of the most common malignant Introduction diseases and a major threat to public health on a global scale. Non-small-cell lung cancer (NSCLC) has a higher degree of Lung cancer is one of the most common malignant diseases malignancy and a lower 5-year survival rate compared with that and a major threat to public health on a global scale. The main of small-cell lung cancer. NSCLC may be mainly divided into types of lung cancer are small-cell lung cancer (SCLC) and non- two pathological subtypes, adenocarcinoma and squamous cell small-cell lung cancer (NSCLC). NSCLC has a higher degree carcinoma. The aim of the present study was to identify disease of malignancy and a lower 5-year survival rate compared with genes based on the gene expression profile and the shortest path SCLC, and may be divided into two major histopathological analysis of weighted functional protein association networks subtypes, namely adenocarcinoma (ADC) and squamous cell with the existing protein-protein interaction data from the Search carcinoma (SCC).
    [Show full text]
  • Protein Phosphatase 2A Regulatory Subunits and Cancer
    Biochimica et Biophysica Acta 1795 (2009) 1–15 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbacan Review Protein phosphatase 2A regulatory subunits and cancer Pieter J.A. Eichhorn 1, Menno P. Creyghton 2, René Bernards ⁎ Division of Molecular Carcinogenesis, Center for Cancer Genomics and Center for Biomedical Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands article info abstract Article history: The serine/threonine protein phosphatase (PP2A) is a trimeric holoenzyme that plays an integral role in the Received 7 April 2008 regulation of a number of major signaling pathways whose deregulation can contribute to cancer. The Received in revised form 20 May 2008 specificity and activity of PP2A are highly regulated through the interaction of a family of regulatory B Accepted 21 May 2008 subunits with the substrates. Accumulating evidence indicates that PP2A acts as a tumor suppressor. In this Available online 3 June 2008 review we summarize the known effects of specific PP2A holoenzymes and their roles in cancer relevant pathways. In particular we highlight PP2A function in the regulation of MAPK and Wnt signaling. Keywords: Protein phosphatase 2A © 2008 Elsevier B.V. All rights reserved. Signal transduction Cancer Contents 1. Introduction ............................................................... 1 2. PP2A structure and function ....................................................... 2 2.1. The catalytic subunit (PP2Ac).................................................... 2 2.2. The structural subunit (PR65) ................................................... 3 2.3. The regulatory B subunits ..................................................... 3 2.3.1. The B/PR55 family of B subunits .............................................. 3 2.3.2. The B′/PR61 family of β subunits ............................................. 4 2.3.3. The B″/PR72 family of β subunits ............................................
    [Show full text]
  • Structural Studies on PP2A and Methods in Protein Production
    Structural studies on PP2A and Methods in Protein Production Auður Magnúsdóttir ©Auður Magnúsdóttir, pp.1-53, Stockholm 2008 ISBN 978-91-7155-750-6 Printed in Sweden by Universitetsservice AB, Stockholm 2008 Distributor: Department of Biochemistry and Biophysics, Stock- holm University All previously published papers are reprinted with permission from the publisher To Elski Pelski Abstract PP2A is a major phosphatase in the cell that participates in multiple cell signaling pathways. It is a heterotrimer of a core dimer and variable regulatory subunits. Details of its structure, function and regulation are slowly emerging. Here, the structure of two regulators of PP2A are de- scribed; PTPA and B56γ. PTPA is a highly conserved enzyme that plays a crucial role in PP2A activity but whose biochemical function is still unclear. B56γ is a PP2A regulatory subunit linked to cancer and the structure pre- sented here of B56γ in its free form is particularly valuable in light of the recent structures of the PP2A holoenzyme and core dimer. Protein production is a major bottleneck in structural genomic pro- jects. Here, we describe two novel methods for improved protein produc- tion. The first is a colony based screening method where any DNA library can be screened for soluble expression of recombinant proteins in E.coli. The second method involves improvements of the well established IMAC purification method. We have seen that a low molecular weight component of E.coli lysate decreases the binding capacity of IMAC columns and by removing the low molecular weight components, recombinant proteins only present at low levels in E.coli lysate can be purified, which has previously been believed to be unfeasible.
    [Show full text]
  • Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia
    International Journal of Molecular Sciences Review Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia Oriol de Barrios * and Maribel Parra * Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles s/n, 08916 Barcelona, Spain * Correspondence: [email protected] (O.d.B.); [email protected] (M.P.); Tel.: +34-93-557-28-00 (ext. 4222) (O.d.B.); +34-93-557-28-00 (ext. 4210) (M.P.) Abstract: B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is a highly aggressive malig- nancy, with poorer prognosis in infants than in adults. A genetic signature has been associated with this outcome but, remarkably, leukemogenesis is commonly triggered by genetic alterations of embryonic origin that involve the deregulation of chromatin remodelers. This review considers in depth how the alteration of epigenetic profiles (at DNA and histone levels) induces an aberrant phenotype in B lymphocyte progenitors by modulating the oncogenic drivers and tumor suppressors involved in key cancer hallmarks. DNA methylation patterns have been widely studied in BCP-ALL and their correlation with survival has been established. However, the effect of methylation on histone residues can be very different. For instance, methyltransferase KMT2A gene participates in chromosomal rearrangements with several partners, imposing an altered pattern of methylated H3K4 and H3K79 residues, enhancing oncogene promoter activation, and conferring a worse outcome on affected infants. In parallel, acetylation processes provide an additional layer of epigenetic regulation and can alter the chromatin conformation, enabling the binding of regulatory factors. Therefore, an integrated knowledge of all epigenetic disorders is essential to understand the molecular basis of Citation: de Barrios, O.; Parra, M.
    [Show full text]